Igarashi M

No ORCID on file · 7 papers in corpus · active 1990-2004

Study types

  • article 4
  • letter 3

Condition tags

  • endometriosis 7
  • dysmenorrhea 3
  • adenomyosis 3
  • dyspareunia 1
letter 2004
Fertility and Sterility ·doi:10.1016/j.fertnstert.2003.11.058

A danazol-loaded intrauterine device (IUD) containing 300-400 mg of danazol was inserted for 6 months in a group of women (n = 18) (median age 36.6 years; age range: 30 to 46 years) with a histologic diagnosis of endometriosis, referred for…

letter 2003
Fertility and Sterility ·doi:10.1016/s0015-0282(03)01117-8
article 2001
Nihon rinsho. Japanese journal of clinical medicine
letter 2000
Fertility and Sterility ·doi:10.1016/s0015-0282(00)00624-5
article 1998
Gynecologic and obstetric investigation ·doi:10.1159/000009999

CA-125 is abundantly secreted from ovarian endometriotic cysts, but is not specific to endometriosis. In order to develop a new, more specific diagnostic marker for endometriosis, the iron concentrations in various ovarian cysts were assaye…

article 1998
Human Reproduction ·doi:10.1093/humrep/13.7.1952

Danazol is routinely administered orally to inhibit ovulation and to treat pelvic endometriosis. However, recent evidence suggests that danazol can act directly on endometriotic tissue in vitro to inhibit DNA synthesis and induce apoptosis.…

article 1990
Asia-Oceania journal of obstetrics and gynaecology ·doi:10.1111/j.1447-0756.1990.tb00207.x

In order to investigate the effect of the local direct action of danazol upon endometriosis, intravaginal and intrauterine application were tried. A vaginal danazol ring containing 2 g to 3.5 g danazol not only reduced both dysmenorrhea and…